These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31755461)

  • 1. Severe necrotising inflammatory skin reaction to topical 5-fluorouracil.
    Gokhale NS
    Indian J Ophthalmol; 2019 Dec; 67(12):2066-2068. PubMed ID: 31755461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of an adverse reaction to topical 5-fluorouracil in irradiated skin.
    Lambert T; Mullinax K; Smith J
    J Drugs Dermatol; 2006 Mar; 5(3):282-3. PubMed ID: 16573264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study.
    Parrozzani R; Lazzarini D; Alemany-Rubio E; Urban F; Midena E
    Br J Ophthalmol; 2011 Mar; 95(3):355-9. PubMed ID: 20693564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
    Venkateswaran N; Mercado C; Galor A; Karp CL
    Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized pustular drug eruption caused by topical 5-fluorouracil.
    Nemer KM; Solus JF; Schaffer A; Rosman IS; Lee SJ
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28834062
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
    Bahrami B; Greenwell T; Muecke JS
    Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous recall reactions with systemic fluorouracil.
    Kirkup ME; Narayan S; Kennedy CT
    Dermatology; 2003; 206(2):175-6. PubMed ID: 12592090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular surface squamous neoplasia treated with topical interferon α 2b.
    Pujari A
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28100578
    [No Abstract]   [Full Text] [Related]  

  • 10. Conjunctival squamous cell carcinoma treated with topical 5-fluorouracil.
    Midena E; Boccato P; Angeli CD
    Arch Ophthalmol; 1997 Dec; 115(12):1600-1. PubMed ID: 9400803
    [No Abstract]   [Full Text] [Related]  

  • 11. Measuring the severity of topical 5-fluorouracil toxicity.
    Korgavkar K; Firoz EF; Xiong M; Lew R; Marcolivio K; Burnside N; Dyer R; Weinstock MA;
    J Cutan Med Surg; 2014; 18(4):229-35. PubMed ID: 25008439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical 5-Fluorouracil 1% as Primary Treatment for Ocular Surface Squamous Neoplasia.
    Joag MG; Sise A; Murillo JC; Sayed-Ahmed IO; Wong JR; Mercado C; Galor A; Karp CL
    Ophthalmology; 2016 Jul; 123(7):1442-8. PubMed ID: 27030104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimetabolites in ocular surface neoplasia.
    Majmudar PA; Epstein RJ
    Curr Opin Ophthalmol; 1998 Aug; 9(4):35-9. PubMed ID: 10387466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
    Chaugule SS; Park J; Finger PT
    Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study.
    Parrozzani R; Frizziero L; Trainiti S; Testi I; Miglionico G; Pilotto E; Blandamura S; Fassina A; Midena E
    Br J Ophthalmol; 2017 Aug; 101(8):1094-1099. PubMed ID: 27941046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical chemotherapy for ocular surface squamous neoplasia: current status.
    Sepulveda R; Pe'er J; Midena E; Seregard S; Dua HS; Singh AD
    Br J Ophthalmol; 2010 May; 94(5):532-5. PubMed ID: 19776089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical chemotherapy for ocular surface squamous neoplasia.
    Nanji AA; Sayyad FE; Karp CL
    Curr Opin Ophthalmol; 2013 Jul; 24(4):336-42. PubMed ID: 23680759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erosion of psoriatic plaques: an uncommon side-effect of neoadjuvant 5-fluorouracil treatment of colon cancer.
    Wetzig T; Beckheinrich P; Rytter M; Haustein UF
    Br J Dermatol; 2002 Oct; 147(4):824-5. PubMed ID: 12366448
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.
    Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A
    Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic toxicity from occlusive therapy with topical 5-fluorouracil: a case report and review of the literature.
    Sargen M; Wanat KA; Jambusaria A; Rosenbach M; Sobanko J; Miller CJ
    Dermatol Surg; 2012 Oct; 38(10):1756-9. PubMed ID: 22805044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.